LeukoSite
Cambridge
About LeukoSite
LeukoSite provides treatment and cares for inflammatory, autoimmune, cancer applications, and viral diseases.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Total funding: $12.0M
- Funding stage: M&A
- Last round: Post-IPO Equity (Jul 1998)
- Ticker: nasdaq:LKST
- Website: leukosite.com
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/leukosite-2135420 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.